Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
1(20.0%)
N/A
1(20.0%)
Phase 1
1(20.0%)
Phase 2
1(20.0%)
Phase 4
1(20.0%)
5Total
Early Phase 1(1)
N/A(1)
Phase 1(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07127237Early Phase 1Not Yet Recruiting

Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in Adults

Role: lead

NCT05726344Not ApplicableCompleted

Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults

Role: lead

NCT04358497Phase 4Unknown

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

Role: lead

NCT03180424Phase 2Unknown

Impact on Functional Status in Older Adults Treated With L-Carnitine

Role: lead

NCT01750749Phase 1Completed

Cell Therapy for Venous Leg Ulcers Pilot Study

Role: lead

All 5 trials loaded